Search

everythinglearnresearchcommunity

for

Search:↓

Topical rapamycin may effectively treat fibrous papules on the face.

Two women were diagnosed with a rare melanoma that looked like hair loss but was actually a type of skin cancer.

CD19-CAR T cell therapy may help regenerate skin in systemic sclerosis.

Hair loss in Lichen Planopilaris is caused by immune system issues damaging hair follicles and stem cells.

Primary care is key in managing PCOS, focusing on lifestyle changes and medications like birth control and metformin.

Moderate facial angiofibroma significantly reduces quality of life compared to almost-clear cases, highlighting the benefits of treatment.

Unique fat cells near fibrotic areas contribute to systemic sclerosis progression.

Cladribine has known risks and potential new safety concerns, requiring careful monitoring.

Teriflunomide helps reduce multiple sclerosis symptoms and is safe for most patients.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

Teriflunomide is an effective and safe first-line oral treatment for relapsing multiple sclerosis.

The anti-viral drug Elvitegravir may protect brain cells from damage related to neurodegenerative diseases.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

Teriflunomide is effective and generally safe for treating relapsing-remitting multiple sclerosis.

An elderly woman's swollen, painful foot was found to be caused by a rare type of bone lymphoma, which improved with radiation treatment.

Taking vitamin D might improve life for MS patients and reduce skin side effects from alemtuzumab treatment.

Blood vessel patterns in skin diseases relate to certain blood markers in systemic sclerosis but not in psoriasis or psoriatic arthritis, and may indicate circulation issues in alopecia.

Teriflunomide is effective and generally safe for treating relapsing multiple sclerosis, reducing relapse rates and disability progression.

Women with PCOS are more than twice as likely to develop nonalcoholic fatty liver disease.

Blocking the NOTCH pathway can prevent fibrosis in systemic sclerosis.

Scarring alopecia involves increased immune cells and specific gene changes near damaged hair follicles.

Fibroblast changes in systemic sclerosis may help understand disease severity and treatment.

TSC2-/meth cells can cause skin lesions, hair growth, and lung issues, and may be treated with chromatin remodeling agents.

Ayurvedic treatments can improve symptoms and quality of life for systemic sclerosis patients.

Recognizing CVG can help diagnose systemic amyloidosis early.

Exosomes could revolutionize skin disease treatment and healing.

An intact skin barrier is crucial to prevent infection in cases of tether-induced tenosynovitis.

HPH-15, a new compound, effectively reduces skin fibrosis in experiments without causing harm.

The study found unique skin changes in a rare type of alopecia linked to a skin condition called linear morphea.

Classifying hair diseases, like alopecia, is difficult and needs more research to understand their causes.